Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

weight.

Of the placebo patients who completed the trial, 34.9% and 16.1% achieved at least 5% and 10% weight loss, respectively, and the average weight loss was 8.7 pounds, or 3.9%. The top quartile of lorcaserin patients lost 36% more body weight than the top quartile of placebo patients.

For the patients treated with 10 mg of lorcaserin dosed once daily (QD) and completing the 52-week trial according to protocol, 53.1% lost at least 5% of their body weight and 26.3% lost at least 10% of their body weight. The average weight loss in the lorcaserin 10 mg once daily group was 14.3 pounds, or 6.5%. As with the higher dose, all results were highly statistically significant (p<0.0001 compared to placebo).

Intent-to-Treat Last Observation Carried Forward (ITT-LOCF) Results

Measurements of efficacy using ITT-LOCF analysis also showed that lorcaserin met all primary endpoints. This analysis includes all patients who were randomized and returned for at least one weight measurement. Patients treated with 10 mg of lorcaserin once or twice daily achieved highly statistically significant categorical and average weight loss after 12 months:

Lorcaserin 10 mg Twice Daily

  • 47.2% of patients treated with 10 mg of lorcaserin dosed twice daily lost at least 5% of their body weight compared to 25.0% for placebo (p<0.0001). This result satisfies the efficacy benchmark in the most recent FDA draft guidance which provides that a weight-management product can be considered effective if the proportion of patients who lose at least 5% of baseline body weight in the active-product group is at least 35%, is approximately double the proportion in the placebo-treated group, and the difference between groups is statistically significant;
  • 22.6% of patients treated with 10 mg of lorcaserin dosed twice daily lo
    '/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical ... can be the difference between a product,s success or ... map and stratify KOL targets – and then to ... type of strong relationships upon which successful KOL engagement ... pharma companies have identified internal inconsistencies in their KOL ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
(Date:8/29/2014)... PARK, Calif. , Aug. 29, 2014 ... Medical as CEO and member of the Board of ... decades of medical device development and commercialization experience, including ... field. Mr. Engelson previously served as a Partner of ... as President and CEO of two Foundry start-ups. Mr. ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... LAKES, N.J. and HOUSTON, April 13, 2011 BD ... and Waste Management Healthcare Solutions, a subsidiary of Waste ... an agreement to recycle medical sharps waste from hospitals ... the BD ecoFinity™ Life Cycle Solution, an innovative service ...
... ATLANTA, April 12, 2011 Digital Assent ... finalist for this year,s "Top Up-and-Coming Entrepreneur" award, which will ... Innovation Summit from TiE Atlanta, an organization whose mission is ... In 2009 Ibbotson founded Digital Assent and launched its ...
Cached Medicine Technology:BD and Waste Management Launch Initiative to Recycle Medical Sharps 2BD and Waste Management Launch Initiative to Recycle Medical Sharps 3BD and Waste Management Launch Initiative to Recycle Medical Sharps 4Digital Assent CEO Selected as Finalist for 2011 Southeast Entrepreneur Awards 2
(Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The ... oral anticoagulants in pulmonary embolism are published today ... at ESC Congress by Professor Stavros V. Konstantinides ... "2014 ESC Guidelines on the diagnosis and management ... in European Heart Journal (1) and on the ...
(Date:8/29/2014)... 30, 2014 Indosoft, Inc. , ... announces the release of its most advanced contact center ... of new features as well as updates to existing ... , Q-Suite functionality on the presentation side has received ... into the script builder. This WYSIWYG editor allows ...
(Date:8/29/2014)... 29, 2014 According to the latest review ... to lose weight quickly, safely and naturally. The new method ... be amazingly fast, too. , Daily Gossip writes in ... not only teach patients how to eliminate the extra pounds, ... results when it comes to body modeling. , The ...
(Date:8/29/2014)... The new review that can be read on ... system that will permanently eliminate the symptoms of this disease. ... achieve a cure in as fast as 30 to 60 ... about one week. , The Tinnitus Miracle review indicates ... mild hearing loss, pain in the ear and dizziness. Read ...
(Date:8/29/2014)... August 29, 2014 Panic attacks are ... the feeling of intense stress and fear, which appears ... the sufferer, causing insecurity and affecting relationships. , A ... there are many symptoms that patients can deal with. ... these symptoms. Overcoming panic attacks is extremely important for ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2
... N.C., March 25 There is no guarantee ... after its initial launch. A,necessary first step for ... that ensures needed resources -- both financial and,staffing ... a study by benchmarking,leader Best Practices, LLC., ...
... Stanford University School of Medicine,s Todd Ferris, Associate ... of Information Privacy and Security; ... Engineer, WHAT: "Improving Network Security and Management", WHEN: ... EDUCAUSE Western Regional Conference 2008 ...
... March 25 Laerdal Medical,Corporation announces a ... MedAssets Supply Chain Systems has awarded Laerdal,a ... Products." The,contract is effective January 1 through ... ), Bruce Cadwell, Laerdal,s National ...
... Cancer with State-of-the-Art Technology, EAST RUTHERFORD, N.J., ... of the nation,s top 10 public relations firms, ... roster. Developed in New,Zealand, MoleSafe is a state-of-the-art ... moles and other suspicious lesions to,help detect early ...
... 25 Almost Family, Inc.,(Nasdaq: AFAM ) today ... home health agency owned by Apex Home Healthcare,Services, L.L.C. ... Company Comments on Combination, "We are very pleased ... of Apex to our Company, and we are excited ...
... pathogens - including ,superbug, MRSA-responsible ... March 25 The U.S. Environmental Protection,Agency (EPA) ... public health claims. These public health claims acknowledge ... harmful, potentially deadly,bacteria. Copper is the first solid ...
Cached Medicine News:Health News:Successful Drug Re-Launch Hinges on Organizational Backing 2Health News:Stanford University School of Medicine to Address 'Improving Network Security and Management' at EDUCAUSE Western Regional Conference 2008 Using Lancope's StealthWatch System for Network Behavior Analysis 2Health News:Laerdal Medical Announces Strategic Relationship 2Health News:MWW Group Retained by MoleSafe 2Health News:Almost Family Announces Acquisition of Apex Home Health 2Health News:Almost Family Announces Acquisition of Apex Home Health 3Health News:Almost Family Announces Acquisition of Apex Home Health 4Health News:U.S. EPA Approves Registration of Antimicrobial Copper Alloys 2
Shandon Laser MicroWriter is a laser labeling system developed specifically for anatomical pathology....
Modular Slide Storage Cabinet has a durable cold rolled steel construction with baked on epoxy finish. Drawers slide smoothly and quietly....
Store microscope slides with ease, speed, efficiency....
... offers special drawers for just about everything imaginable ... microscopy laboratory. Each box is designed for long ... the advantages of wood over metal systems is ... as a subtle kind of desiccator and insulator, ...
Medicine Products: